• Oridonin, NF-κB, and TAA-Induced Bone Loss

  2026-08-09

  Jin et al. show that oridonin counteracts thioacetamide-associated skeletal injury through two complementary mechanisms: suppressing MAPK/NF-κB-driven osteoclastogenesis and restoring BMP-2/RUNX2-related osteoblast differentiation. The study provides a preclinical framework for evaluating compounds that address both excessive bone resorption and inadequate bone formation.

• Valemetostat (DS-3201) in EZH2 Research

  2026-08-08

  Valemetostat (DS-3201) is a potent EZH2-focused epigenetic tool for lymphoma models and adoptive T-cell studies. This workflow-oriented guide covers exposure design, CAR-T/TCR-T combination assays, controls, and troubleshooting for translational researchers.

• N6-Methyl-dATP for Fidelity and Epigenetic Assays

  2026-08-07

  N6-Methyl-dATP enables controlled substitution experiments that reveal how adenine methylation affects polymerase activity, DNA synthesis, and nucleic-acid recognition. This article translates those capabilities into practical workflows for DNA replication fidelity studies and AML-focused methylation research, with controls and troubleshooting guidance.

• FXR Protein Phase Separation Orchestrates β-Coronavirus Repl

  2026-08-07

  Li et al. (2024) identify fragile X–related (FXR) proteins as key host factors that drive the clustering of coronavirus replication organelles via liquid–liquid phase separation (LLPS). This discovery elucidates a host-mediated mechanism enabling efficient β-coronavirus proliferation and opens new avenues for targeted virology research.

• Gepotidacin in Antibacterial Research: Novel Mechanisms and

  2026-08-06

  Explore how Gepotidacin, a first-in-class bacterial DNA replication inhibitor, is transforming antibacterial research and clinical strategies against resistant pathogens. Learn about its unique mechanism, real-world trial results, and advanced applications in laboratory workflows.

• Senolytic Effects of L. plantarum DS0037 Nanovesicles in Agi

  2026-08-06

  The referenced study identifies exosome-like nanovesicles from Lactobacillus plantarum DS0037 as potent senolytic and senomorphic agents, selectively reducing viability and modulating gene expression in senescent cells. These findings highlight a promising, natural anti-aging approach with potential applications in skin health and senescence-targeted research.

• 4μ8C: Precision IRE1 RNase Inhibition for ER Stress Studies

  2026-08-05

  4μ8C empowers researchers to dissect unfolded protein response signaling with unparalleled selectivity, enabling precise modulation of ER stress pathways in cancer and cellular stress models. Its optimized workflow compatibility, when handled with care, reveals mechanistic insights unattainable by broader-spectrum inhibitors.

• SAG in Translational Research: Unlocking Hedgehog Pathway Po

  2026-08-05

  This thought-leadership article explores the strategic application of Smoothened Agonist (SAG) in translational science. By integrating mechanistic insights, recent experimental findings, and competitive guidance, we outline how researchers can leverage SAG to drive progress in regenerative medicine, neuroprotection, and immune modulation. Drawing on robust evidence and field-tested protocols, we highlight both the promise and complexity of Hedgehog pathway activation—framing APExBIO’s SAG as a cornerstone for advanced translational research.

• Cy7 NHS Ester: Technical Guide for Near-Infrared Protein Lab

  2026-08-04

  Cy7 NHS ester offers a sulfonated, highly water-soluble near-infrared dye solution optimized for labeling amino groups on proteins and peptides, addressing challenges of denaturation and dye aggregation in sensitive biomolecule workflows. It is suitable for applications requiring robust near-infrared fluorescent imaging in vitro or in vivo, but is not appropriate for targets lacking primary amines or for protocols that require long-term dye solution storage.

• Topotecan HCl: Mechanistic Precision for Translational Oncol

  2026-08-04

  Explore how Topotecan HCl, a topoisomerase 1 inhibitor, is redefining translational cancer research. This thought-leadership article blends mechanistic insight, advanced in vitro validation, and strategic guidance, expanding on recent evidence and competitive protocols to offer a visionary roadmap for maximizing antitumor research impact.

• DMG-PEG2000-NH2: Applied Workflows for Lipid Nanoparticle De

  2026-08-03

  DMG-PEG2000-NH2 accelerates precision bioconjugation for lipid nanoparticle (LNP) and liposome drug delivery, optimizing stability and therapeutic payload encapsulation. This guide translates cutting-edge research into actionable protocols, troubleshooting tactics, and comparative advantages for experimental success.

• Indazole/Indole Glucagon Receptor Antagonists: Synthesis and

  2026-08-03

  This study introduces a novel series of indazole- and indole-based glucagon receptor antagonists targeting type 2 diabetes mellitus. Through innovative scaffold design and optimized synthetic strategies, the work identifies potent, orally active compounds with strong in vitro and in vivo efficacy, providing a foundation for further antidiabetic drug development.

• Translating HDM2 Inhibition: JNJ-26854165 in Modern Cancer R

  2026-08-02

  This thought-leadership article navigates the evolving landscape of p53 pathway modulation in cancer, with a mechanistic and translational focus on JNJ-26854165 (Serdemetan). Integrating evidence from in vitro methodologies, competitive benchmarking, and workflow-driven recommendations, the piece delivers strategic guidance for researchers advancing anti-proliferative and radiosensitization studies. Unique to this article is a synthesis of protocol nuance, workflow optimization, and vision for future clinical translation, all grounded in recent scholarship and APExBIO’s product intelligence.

• Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo

  2026-08-01

  Vacuolin-1 delivers unmatched specificity for dissecting lysosomal exocytosis, redefining experimental rigor in membrane repair and lysosome-mediated trafficking studies. This guide translates recent cartilage pathology discoveries into actionable protocols, troubleshooting advice, and advanced comparative workflows powered by Vacuolin-1 from APExBIO.

• HOBt (1-Hydroxybenzotriazole): Enabling Complex Peptide Desi

  2026-07-31

  Explore how HOBt (1-Hydroxybenzotriazole) advances amide bond formation and peptide synthesis. This article offers a deep dive into mechanistic insights, recent innovations, and practical guidance for minimizing epimerization, setting it apart from standard protocol discussions.

16742 records 1/1117 page Next 12345 下5页 Last page